The World Health Organization wants to tackle inequity and bureaucracy relating to clinical trials. Will its latest guidance make a difference? Anna Volkmer reports During the covid-19 pandemic the UK ...

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine demand and pipeline ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

A former NYU housing manager is suing the university for religious-based discrimination, claiming he was wrongfully ...

O n Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Former UK Prime Minister Boris Johnson recently spoke as part of the Society of the Four Arts' Esther B. O’Keeffe Speaker ...

Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...

The Jan. 22 report noted the challenges of distributing vaccines among different communities with varying risk factors.

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

I have heard many reasons residents haven’t accepted the vaccine: Vaccine burnout (too many vaccines being recommended like ...

The narrative is false that the COVID vaccine was rushed and not properly tested. It and other vaccines are safe and ...